Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 44626 - 44650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Gatifloxacin	Approved Investigational Withdrawn	GCG	2641	upregulated	gatifloxacin results in increased expression of GCG mRNA	2q24.2	A22200
Gatifloxacin	Approved Investigational Withdrawn	PCSK1	5122	upregulated	gatifloxacin results in increased expression of PCSK1 mRNA	5q15	A22200
Gefitinib	Approved Investigational	ADORA1	134	downregulated	gefitinib results in decreased expression of ADORA1 mRNA	1q32.1	A22747
Gefitinib	Approved Investigational	CAV1	857	upregulated	gefitinib results in increased expression of CAV1 mRNA	7q31.2	A22748
Gefitinib	Approved Investigational	CD14	929	upregulated	[gefitinib promotes the reaction arsenic trioxide] which results in increased expression of CD14 mRNA	5q31.3	A20775
Gefitinib	Approved Investigational	CDKN2B	1030	upregulated	gefitinib results in increased expression of CDKN2B mRNA	9p21.3	A22749
Gefitinib	Approved Investigational	CGRRF1	10668	upregulated	gefitinib results in increased expression of CGRRF1 mRNA	14q22.2	A22747
Gefitinib	Approved Investigational	CYP2F1	1572	downregulated	gefitinib results in decreased expression of CYP2F1 mRNA	19q13.2	A22747
Gefitinib	Approved Investigational	DUSP9	1852	downregulated	gefitinib results in decreased expression of DUSP9 mRNA	Xq28	A22747
Gefitinib	Approved Investigational	E2F1	1869	downregulated	gefitinib results in decreased expression of E2F1 mRNA	20q11.22	A22750
Gefitinib	Approved Investigational	EPOR	2057	upregulated	gefitinib results in increased expression of EPOR mRNA	19p13.2	A22747
Gefitinib	Approved Investigational	EPS15	2060	upregulated	gefitinib results in increased expression of EPS15 mRNA	1p32.3	A22747
Gefitinib	Approved Investigational	FGF6	2251	upregulated	gefitinib results in increased expression of FGF6 mRNA	12p13.32	A22747
Gefitinib	Approved Investigational	GADD45A	1647	upregulated	gefitinib results in increased expression of GADD45A mRNA	1p31.3	A22747
Gefitinib	Approved Investigational	GADD45G	10912	downregulated	gefitinib results in decreased expression of GADD45G mRNA	9q22.2	A22747
Gefitinib	Approved Investigational	GARS	2617	upregulated	gefitinib results in increased expression of GARS mRNA	7p14.3	A22747
Gefitinib	Approved Investigational	GNB2	2783	downregulated	gefitinib results in decreased expression of GNB2 mRNA	7q22.1	A22747
Gefitinib	Approved Investigational	GUCY2D	3000	downregulated	gefitinib results in decreased expression of GUCY2D mRNA	17p13.1	A22747
Gefitinib	Approved Investigational	IFI6	2537	downregulated	gefitinib results in decreased expression of IFI6 mRNA	1p35.3	A22747
Gefitinib	Approved Investigational	KEAP1	9817	upregulated	gefitinib results in increased expression of KEAP1 mRNA	19p13.2	A22751
Gefitinib	Approved Investigational	LEPR	3953	downregulated	gefitinib results in decreased expression of LEPR mRNA	1p31.3	A22747
Gefitinib	Approved Investigational	MLH1	4292	downregulated	gefitinib results in decreased expression of MLH1 mRNA	3p22.2	A22747
Gefitinib	Approved Investigational	NFKB1	4790	downregulated	gefitinib results in decreased expression of NFKB1 mRNA	4q24	A22747
Gefitinib	Approved Investigational	NPTX2	4885	downregulated	gefitinib results in decreased expression of NPTX2 mRNA	7q22.1	A22747
Gefitinib	Approved Investigational	NRL	4901	downregulated	gefitinib results in decreased expression of NRL mRNA	14q11.2-q12	A22747

Displaying entries 44626 - 44650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability